Persistence Pays Off for Praxis as Important Tremor Drug Succeeds in Two Pivotal Research
Seven months in the past, unbiased scientific trial observers peeked at interim knowledge for Praxis Precision Medicines’ important tremor drug and advisable stopping the Section 3 research. Praxis saved going. On Thursday, the biotech reported successful results which have the corporate getting ready to speak to the FDA a few submission looking for regulatory approval […]









